
Rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) are chronic inflammatory diseases that greatly influence the quality of life of those affected. To maximise patient outcomes, PerPrev-CID aims to advance early prediction and prevention, analysing multidimensional patient data – including molecular, clinical and lifestyle – and integrating home-based monitoring and self-sampling solutions. The project also focuses on nutritional interventions targeting the intestines to evaluate their impact on immune and microbiome health, alongside strong patient involvement in research. By advancing personalised preventive approaches, PerPrev-CID seeks to improve clinical outcomes, enhance quality of life, and reduce the burden of these diseases across Europe.


